Applications are invited for a fully-funded three year PhD to commence in October 2019. The PhD will be based in the School of Pharmacy and Biomedical Sciences and will be supervised by Dr Sarah Fouch and Dr James Brown.
Antimicrobial resistance (AMR) is a frequent problem in the treatment of disease caused by several clinical bacterial pathogens. In the European Union, antibiotic-resistant infections kill nearly 25,000 patients and represent a total expenditure of £1.5 billion per year.
